R. Kate Kelley

Appearances

PERFORMANCE AND NUTRITIONAL STATUS ARE EACH INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA RECEIVING IMMUNOTHERAPY
Date
May 20, 2024
Management of advanced hepatocellular carcinoma (HCC) has been transformed by immune checkpoint inhibitors (ICIs), which are now first-line systemic therapies…
Presenter
Madeleine Hu
Speakers
R. Kate Kelley
Jennifer Lai
Michael Li